Physician profile
Janice Ray
NPI 1154547040
$587.34
in general payments reported to CMS, 2019-2025
12 companies · $94.24 in 2025
The $94.24 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.34 · 2022: $42.85 · 2024: $376 · 2025: $94.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $253.92 | 2024 | Ycanth |
| Glaxosmithkline, LLC. | $64.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $56.69 | 2021-2024 | Vaxelis, Vaxneuvance, M-M-R II |
| Novo Nordisk INC | $29.91 | 2024 | Sogroya |
| Kyowa Kirin, INC. | $28.40 | 2025 | |
| Sanofi Pasteur INC. | $26.87 | 2025 | |
| Dynavax Technologies Corporation | $26.51 | 2024 | Heplisav-B |
| Ascendis Pharma Endocrinology INC | $24.22 | 2024 | |
| Neurocrine Biosciences, INC. | $23.61 | 2025 | |
| Phadia US INC. | $21.75 | 2021 | |
| Cranial Technologies, INC | $15.36 | 2025 | Doc Band |
| Pfizer INC. | $15.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.